INTERESTing biomarker to select IDEAL patients for epidermal growth factor receptor tyrosine kinase inhibitors: yes, for EGFR mutation analysis, others, I PASS.

Source:http://linkedlifedata.com/resource/pubmed/id/20038722

J. Clin. Oncol. 2010 Feb 10 28 5 713-5

Download in:

View as

General Info

PMID
20038722